Authors
Loading...
Randomized trial assesses TGF-beta's effects on human tenon fibroblasts, suggesting therapeutic targets for scarring.
Meyer‐ter‐Vehn et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: